Wealth Enhancement Advisory Boosts Stake 38.9%, Golden Cross Signals and Q4 Growth Forecast
Wealth Enhancement Advisory Services LLC increased its stake in Align Technology by 38.9% to 15,551 shares valued at $2.03 million in Q3. The stock’s 50-day moving average just crossed above its 200-day for a golden cross while analysts see Q4 revenue rising 3.9% and EPS climbing 22.5%.
1. Wealth Enhancement Advisory Boosts Align Technology Stake
Wealth Enhancement Advisory Services LLC enlarged its position in Align Technology by 38.9% during the third quarter, according to its latest SEC filing. The advisory firm acquired an additional 4,359 shares, bringing its total holding to 15,551 shares. At quarter end, the position was valued at approximately $2.03 million, reflecting the fund’s confidence in the orthodontics and digital dentistry specialist’s medium-term growth prospects.
2. Major Institutional Movements Highlight Broad Investor Interest
Other institutional investors also reshaped their exposure to Align Technology over the same period. Nordea Investment Management AB added 132,019 shares, lifting its total to 770,360 shares valued at roughly $95.2 million. Navera Investment Management Ltd. increased its stake by 3.0% to 787,559 shares, worth about $149.1 million. Virginia Retirement Systems initiated a new position of approximately $1.33 million, while QRG Capital Management deployed $306,000 into the stock. Collectively, hedge funds and institutional investors now control 88.43% of the company’s outstanding shares.
3. Third-Quarter Results Exceed Expectations
Align Technology reported third-quarter earnings per share of $2.61, beating analysts’ consensus by $0.23. Revenue climbed 1.8% year-over-year to $995.7 million, surpassing the $980.8 million estimate. The company delivered a net margin of 9.5% and returned 13.96% on equity. Management noted robust demand for its flagship clear aligner system and continued uptake of intraoral scanners, setting the stage for modest revenue growth in the current fiscal year.
4. Analyst Ratings and Technical Indicators Signal Caution and Opportunity
Wall Street sentiment remains mixed: six analysts maintain Buy ratings while nine recommend Hold, yielding a consensus Hold view and an average price target of $176.82. Recent research notes include an upgrade from Hold to Buy by Wall Street Zen and a trimmed target by Evercore ISI, now at $170. Technically, the stock’s 50-day moving average has crossed above its 200-day average—a classic golden cross—suggesting potential upside, though investors remain watchful of valuation metrics such as a price-to-earnings ratio near 31.6 and a beta exceeding 1.8.